Accellacare
Private Company
Funding information not available
Overview
Accellacare is a specialized clinical research site organization that enhances patient access and experience in clinical trials. It operates an integrated network of physical research sites and offers decentralized clinical trial (DCT) solutions, including in-home nursing visits, to reduce participant burden. As a strategic asset within the larger CRO (Contract Research Organization) ICON plc, Accellacare provides sponsors with a patient-centric channel for faster enrollment and improved trial execution. The company represents a hybrid model in the evolving clinical trials landscape, blending traditional site-based research with flexible, digital-enabled services.
Technology Platform
Integrated clinical research service platform combining a network of physical research sites with decentralized clinical trial (DCT) capabilities, including in-home nursing visits and patient-centric recruitment tools.
Opportunities
Risk Factors
Competitive Landscape
Accellacare competes in the clinical trial execution space against other large, integrated CROs (e.g., IQVIA, Parexel, PPD) that have their own site networks, as well as against specialized decentralized clinical trial technology and service providers (e.g., Science 37, Medable). Its differentiation lies in its branded focus on patient experience and its integrated position within ICON's full-service CRO offering.